Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of Biological Chemistry

• Publication date

  1989-10-05

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2550442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines.

  1989cited by this paper
• Studies of topoisomerase-specific antitumor drugs in human lymphocytes using rabbit antisera against recombinant human topoisomerase II polypeptide.

  1989cited by this paper
• Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli.

  1989cited by this paper
• Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins.

  1988cited by this paper
• Hotspot sites for acridine-induced frameshift mutations in bacteriophage T4 correspond to sites of action of the T4 type II topoisomerase.

  1988cited by this paper
• Anion-dependent modulations of DNA topoisomerase II-mediated reactions in potassium-containing solutions.

  1988cited by this paper
• Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.

  1988cited by this paper
• Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22.

  1988cited by this paper
• Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.

  1988cited by this paper
• Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.

  1988cited by this paper
• Cross-sensitivity to topoisomerase II inhibitors in cytotoxic drug-hypersensitive Chinese hamster ovary cell lines.

  1987cited by this paper
• Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei.

  1987cited by this paper
• Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26).

  1987cited by this paper
• Comparison of the effects of treatment with the polyamine analogue N1,N8 bis(ethyl)spermidine (BESpd) or difluoromethylornithine (DFMO) on the Topoisomerase II mediated formation of 4'-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA) induced cleavable complex in the human lung carcinoma line NC

  1987cited by this paper
• Development and characterization of a human myelogenous leukemia cell line resistant to 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide.

  1987cited by this paper
• Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.

  1987cited by this paper
• Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.

  1987cited by this paper
• The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.

  1987cited by this paper
• Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells.

  1987cited by this paper
• Topoisomerase-specific drug sensitivity in relation to cell cycle progression

  1987cited by this paper
• Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.

  1987cited by this paper
• Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.

  1987cited by this paper
• Proliferation dependence of topoisomerase II mediated drug action.

  1986cited by this paper
• Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.

  1986cited by this paper
• Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target.

  1986cited by this paper
• DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.

  1986cited by this paper
• Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.

  1986cited by this paper
• Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II.

  1986cited by this paper
• Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.

  1986cited by this paper
• Eukaryotic topoisomerase II. Characterization of enzyme turnover.

  1986cited by this paper
• Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity.

  1986cited by this paper
• The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).

  1986cited by this paper
• Rapid detection and isolation of covalent DNA/protein complexes: application to topoisomerase I and II.

  1984cited by this paper
• Further characterization of the P85gag-mos -associated protein kinase activity.

  1984cited by this paper
• Biochemical characterization of topoisomerase I purified from avian erythrocytes.

  1983cited by this paper
• DNA topoisomerase II from Drosophila melanogaster. Purification and physical characterization.

  1983cited by this paper
• Cleavage of DNA by mammalian DNA topoisomerase II.

  1983cited by this paper
• Double strand DNA cleavage by type II DNA topoisomerase from Drosophila melanogaster.

  1983cited by this paper
• Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.

  1982cited by this paper
• Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl-9-hydroxyellipticinium.

  1982cited by this paper
• The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei.

  1982cited by this paper
• Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.

  1981cited by this paper

• Effects of DNA topoisomerase IIα splice variants on acquired drug resistance

  2020cites this paper
• Genetic and epigenetic modulation of drug resistance in cancer: Challenges and opportunities.

  2020cites this paper
• hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase IIα in Human Leukemia K562 Cells with Acquired Resistance to Etoposide

  2019cites this paper
• Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling

  2019cites this paper
• Resistance to Anti-Cancer Therapeutics

  2019cites this paper
• Pathways Linked to Cancer Chemoresistance and Their Targeting by Nutraceuticals

  2018cites this paper
• Medicinal uses of Galenia africana: A study of the antimicrobial, antifungal and anticancer properties

  2017cites this paper
• Identification of doxorubicin drug resistance mechanisms by using genomic techniques

  2015cites this paper
• Drug Resistance in Cancer: An Overview

  2014cites this paper
• Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells

  2012cites this paper
• The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase IIα.

  2012cites this paper
• Acridine Yellow G Blocks Glioblastoma Growth via Dual Inhibition of Epidermal Growth Factor Receptor and Protein Kinase C Kinases*

  2012cites this paper
• Topoisomerase II Inhibitors: Chemical Biology

  2012cites this paper
• Functions of human DNA topoisomerases in cel proliferation and effects of anticancer drungs and natural compounds on the type II enzymes

  2010cites this paper
• A diazirine-based photoaffinity etoposide probe for labeling topoisomerase II.

  2010cites this paper
• Effect of phenazine compounds XR11576 and XR5944 on DNA topoisomerases

  2009cites this paper
• Novel HIV-1 therapeutics through targeting altered host cell pathways

  2009cites this paper
• 9-aminoacridine Inhibition of HIV-1 Tat Dependent Transcription

  2009cites this paper
• Isolation and Characterization of mAMSA-hypersensitive Mutants

  2008cites this paper
• Synthesis and evaluation of unsymmetrical polyamine derivatives as antitumor agents.

  2008cites this paper
• Novobiocin Expressing Multidrug Resistant Tumor Cell Lines by Reversal of Etoposide Resistance in Non-P-Glycoprotein

  2006cites this paper
• Multidrug Resistant Human Small Cell Lung Carcinoma Cells-aniside in Atypical m-( 9-Acridinylamino ) methanesulfon-′ Topoisomerase II as a Target of VM-26 and 4 Updated

  2006cites this paper
• Advances in Brief W-^ S-DiacetoxypentyOdoxorubicin : A Novel Anthracycline Producing DNA Interstrand Cross-Linking and Rapid Endonucleolytic Cleavage in Human Leukemia Cells 1

  2006cites this paper
• Line Low Level of Drug Resistance in a Chinese Hamster Ovary Cell Attenuated Topoisomerase II Content Directly Correlates with a Updated

  2006cites this paper
• Altered Topoisomerase Ila in a Drug-resistant Small Cell Lung Cancer Cell Line Selected in VP-161

  2006cites this paper
• ; Realizationof theTherapeuticPotentialof CTLA-4Blockadein Low-Dose Chemotherapy-treated Tumor-bearing Mice1

  2006cites this paper
• Anaplastic Astrocytoma Cells Treated with Topotecan Subcellular Redistribution of DNA Topoisomerase I in Updated

  2006cites this paper
• Absence of Topoisomerase IIßin an Amsacrine-resistant Human Leukemia Cell Line with Mutant Topoisomerase Ha1

  2006influential citation
• TOPOISOMERASE II AND DRUG SENSITIVITY IN HUMAN LUNG CANCER CELLS MATERIALS AND METHODS Cell Lines and Cytotoxicity Assay

  2006influential citation
• Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.

  2006cites this paper
• Sartorelli and Cross-Resistant to Other Topoisomerase II-targeted Drugs Monomyelocytic Leukemia Cell Line Resistant to Novobiocin + Development and Characterization of a WEHI-3 B D Updated

  2006cites this paper
• Bursting on the Scene: How Thalamic Neurons Grab Your Attention

  2006cites this paper
• Altered expression of topoisomerase IIα contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation

  2005influential citation
• Enhances Sensitivity to Topoisomerase II A Targeting Anticancer Drug by Up-Regulating the Promoter Activity

  2005cites this paper
• Adenovirus-mediated human topoisomerase IIα gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells

  2005cites this paper
• Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors.

  2005cites this paper
• A novel role for Bsd2 in the resistance of yeast to adriamycin

  2005cites this paper
• E1A Specifically Enhances Sensitivity to Topoisomerase IIα Targeting Anticancer Drug by Up-Regulating the Promoter Activity

  2005cites this paper
• The effect of staurosporine on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells

  2004cites this paper
• Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes

  2004cites this paper
• Reduced levels of topoisomerase IIα and IIβ in a multidrug-resistant lung-cancer cell line

  2004cites this paper
• Functions of yeast helicase Ssl2p that are essential for viability are also involved in protection from the toxicity of adriamycin.

  2004cites this paper
• Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent

  2004cites this paper
• In vivo etoposide-resistant C6 glioma cell line: Significance of altered DNA topoisomerase II activity in multi-drug resistance

  2004cites this paper
• Quinolones and Eukaryotic Topoisomerases

  2003cites this paper
• DNA Topoisomerases in Cancer Therapy

  2003cites this paper
• Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.

  2003cites this paper
• Drug Resistance and Its Clinical Circumvention

  2003cites this paper
• Down-regulation of topoisomerase IIα is caused by up-regulation of GRP78

  2003cites this paper
• Phosphorylation of Serine 1106 in the Catalytic Domain of Topoisomerase IIα Regulates Enzymatic Activity and Drug Sensitivity*

  2003cites this paper
• Mechanism of action of topoisomerase II-targeted anticancer drugs

  2003cites this paper
• Down-regulation of topoisomerase II alpha is caused by up-regulation of GRP78.

  2003cites this paper
• Understanding the action of drugs targeting TOP2: Yeast based systems for unraveling drug mechanisms

  2003cites this paper
• The molecular biology of topoisomerase IIα and its importance in the acquisition of multidrug resistance in cancer

  2002cites this paper
• Interleukin‐1α increases the cytotoxic activity of etoposide against human osteosarcoma cells

  2002cites this paper
• Pro-oxidant and antioxidant mechanisms of etoposide in HL-60 cells: role of myeloperoxidase.

  2001cites this paper
• Topoisomerase II Poisoning by ICRF-193*

  2001cites this paper
• Isolation of covalent enzyme-DNA complexes.

  2001cites this paper
• Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cells.

  2001cites this paper
• Influence of polyamine architecture on the transport and topoisomerase II inhibitory properties of polyamine DNA-intercalator conjugates.

  2001cites this paper
• Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase II α gene transfer is independent of topoisomerase II β

  2001cites this paper
• Cytotoxic mechanism of XK469: resistance of topoisomerase IIbeta knockout cells and inhibition of topoisomerase I.

  2001cites this paper
• Characterization of cell lines resistant to topoisomerase targeting drugs and mechanistic studies of Quinoxaline solid tumor drugs - a new chemical class of topoisomerase II poisons /

  2001cites this paper
• In vitro topo II--DNA complex accumulation and cytotoxicity of etoposide in leukaemic cells from patients with acute myelogenous and chronic lymphocytic leukaemia.

  2001cites this paper
• Mutations at arg486 and glu571 in human topoisomerase IIalpha confer resistance to amsacrine: relevance for antitumor drug resistance in human cells.

  2000cites this paper
• Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells

  2000cites this paper
• Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.

  2000cites this paper
• Altered expression of DNA-topoisomerase IIalpha is associated with increased rate of spontaneous polyploidization in etoposide resistant K562 cells.

  2000cites this paper
• EFEITOS CITOTÓXICOS DO TENIPOSIDE, UM DERIVADO SEMI-SINTÉTICO DAS EPIPODOFILOTOXINAS, SOBRE LINHAGENS CELULARES DE CARCINOMA RENAL HUMANO

  2000cites this paper
• The effect of polyamine homologation on the transport and cytotoxicity properties of polyamine-(DNA-intercalator) conjugates.

  2000cites this paper
• Characterisation of a synergistic interaction between a thymidylate synthase inhibitor, ZD1694, and a novel lipophilic topoisomerase I inhibitor karenitecin, BNP1100: mechanisms and clinical implications.

  1999cites this paper
• Human Breast Cancer Cells Transfer Increases the Sensitivity of Etoposide-resistant Gene α Topoisomerase II Adenovirus-mediated Human Updated

  1999cites this paper
• Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells.

  1999cites this paper
• Synergistic Cytotoxicity, Apoptosis and Protein-linked DNA Breakage by Etoposide and Camptothecin in Human U87 Glioma Cells: Dependence on Tyrosine Phosphorylation

  1999cites this paper
• A importância da seqüência de administração do irinotecan e 5-fluorouracil na inibição da proliferação do carcinoma de cólon humano in vitro

  1999cites this paper
• In vitro Antitumor Activity of TAS‐103, a Novel Quinoline Derivative That Targets Topoisomerases I and II

  1999cites this paper
• Immunoblot analysis and band depletion assays.

  1999cites this paper
• Purification of DNA topoisomerase II from Drosophila melanogaster.

  1999cites this paper
• Mechanism-based chemopreventive strategies against etoposide-induced acute myeloid leukemia: free radical/antioxidant approach.

  1999cites this paper
• Altered drug interaction and regulation of topoisomerase IIbeta: potential mechanisms governing sensitivity of HL-60 cells to amsacrine and etoposide.

  1999cites this paper
• Interferon-alpha Enhances the Sensitivity of Human Osteosarcoma Cells to Etoposide

  1999cites this paper
• Mechanisms of resistance to xenobiotics in human therapy

  1998cites this paper
• Pleiotrope Zytostatikaresistenz (Multidrug resistance) und Hochdosischemotherapie

  1998cites this paper
• Clinical resistance to topoisomerase-targeted drugs.

  1998cites this paper
• Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme.

  1998cites this paper
• Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha.

  1998cites this paper
• Enhanced sensitivity to topoisomerase inhibitors in synchronous CHO cells pre-treated with 5-azacytidine.

  1998cites this paper
• Absence of Topoisomerase IIβ in an Amsacrine-resistant Human Leukemia Cell Line with Mutant Topoisomerase IIα

  1998cites this paper
• Tumor cell resistance to topoisomerase II poisons: role for intracellular free calcium in the sensitization by inhibitors or calcium-calmodulin-dependent enzymes.

  1998cites this paper
• A Mutant Yeast Topoisomerase II (top2G437S) with Differential Sensitivity to Anticancer Drugs in the Presence and Absence of ATP*

  1998cites this paper
• Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha.

  1998cites this paper
• Drug resistance to DNA topoisomerase I and II inhibitors in human leukemia, lymphoma, and multiple myeloma.

  1997cites this paper
• Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.

  1997cites this paper
• Antitumor Activity of a Novel Quinoline Derivative, TAS‐103, with Inhibitory Effects on Topoisomerases I and II

  1997cites this paper
• Altered formation of topotecan-stabilized topoisomerase I-DNA adducts in human leukemia cells.

  1997cites this paper
• Topoisomerase II levels and drug response in small cell lung cancer.

  1997cites this paper
• Chemical synthesis and biological activity of a novel fluorescent etoposide derivative.

  1997cites this paper
• Natural resistance of acute myeloid leukemia cell lines to mitoxantrone is associated with lack of apoptosis

  1997cites this paper
• Differential stabilization of topoisomerase-II-DNA cleavable complexes by doxorubicin and etoposide in doxorubicin-resistant rat glioblastoma cells.

  1997cites this paper
• Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposide.

  1996cites this paper